Blurred or distorted vision
Treatment depends on the severity of keratoconus and whether the condition is progressing.
Glasses or specialty contact lenses may help improve vision by correcting the refractive changes caused by an irregularly shaped cornea. However, vision correction alone does not address the underlying structural changes occurring within the cornea.
Corneal collagen cross-linking is another treatment option for keratoconus. Cross-linking uses riboflavin and ultraviolet light to strengthen the corneal tissue.
For patients with advanced disease, additional treatment options, including corneal transplantation, may be considered.
Northeastern Eye Institute is pleased to offer Epioxa®, an FDA-approved epithelium-on corneal cross-linking treatment for keratoconus in adults and pediatric patients age 13 and older.
Unlike traditional corneal cross-linking, Epioxa does not require removal of the corneal epithelium, the outermost layer of the cornea, during treatment. Epioxa is designed to strengthen the cornea and slow the progression of keratoconus.
Northeastern Eye Institute’s Cornea Center is led by experienced corneal specialists Thomas S. Boland, MD, and Christopher S. Jordan, MD. With extensive experience diagnosing and treating corneal disorders, our team provides personalized care for patients with keratoconus, from comprehensive evaluation and ongoing monitoring to advanced treatment options such as corneal cross-linking.
The Cornea Center has a long history of advancing corneal care in Northeastern Pennsylvania, including participation in keratoconus and FDA research studies.